MedPath

JAMP BILASTINE ORAL SOLUTION

JAMP BILASTINE ORAL SOLUTION

Approved
DIN Number

02448262

Drug Class

Human

Market Date

N/A

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02448262
AIG Number0158051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
Product Specifications
Dosage FormSolution
Route of AdministrationOral
Health Canada Classification

ACTIVE INGREDIENTS (1)

BILASTINEActive
Strength: 2.5 MG / ML
Monograph: BILASTINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.